Rule, S., Dreyling, M., Goy, A., Hess, G., Auer, R., Kahl, B., Hernández-Rivas, J.- Ángel, Qi, K., Deshpande, S., Parisi, L. and Wang, M. (2019) “Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis”, Haematologica. Pavia, Italy, 104(5), pp. e211-e214. doi: 10.3324/haematol.2018.205229.